Lion Point Capital, LP / MCRB1EUR
Lion Point Capital, LP’s Seres Therapeutics Inc Position
Does Lion Point Capital, LP own Seres Therapeutics Inc (MCRB1EUR)? Not currently — the last reported position was 340.8K shares worth $238,533 in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$238,533
Q1 2025
Shares
340.8K
% of Portfolio
+1.52%
Quarters Held
15
position exited
Position History MCRB1EUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 340.8K | $238,533 | +1.52% |
| Q4 2024 | 340.8K | $283,172 | +1.48% |
| Q3 2024 | 340.8K | $322,394 | +0.72% |
| Q2 2024 | 340.8K | $246,643 | +0.45% |
| Q1 2024 | 340.8K | $263,783 | +0.15% |
| Q4 2023 | 340.8K | $477,065 | +0.24% |
| Q3 2023 | 691.8K | $2M | +0.73% |
| Q2 2023 | 691.8K | $3M | +1.50% |
| Q1 2023 | 596.8K | $3M | +1.39% |
| Q4 2022 | 596.8K | $3M | +0.44% |
| Q3 2022 | 626.8K | $3M | +0.71% |
| Q2 2022 | 481.8K | $3M | +0.30% |
| Q1 2022 | 481.8K | $3M | +0.80% |
| Q4 2021 | 481.8K | $4M | +1.08% |
| Q3 2021 | 481.8K | $3M | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of MCRB1EUR.